Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 56Rectal Neoplasms 30Colonic Neoplasms 29Pancreatic Neoplasms 28Neoplasms 20Neoplasm Metastasis 18Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 14Unspecified Adult Solid Tumor, Protocol Specific 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 8Esophageal Neoplasms 8Ovarian Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma 7Adenocarcinoma 7Myelodysplastic Syndromes 6Lung Neoplasms 6Gallbladder Neoplasms 6Breast Neoplasms 6Sarcoma 5Osteosarcoma 5Liver Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Bile Duct Neoplasms 5Triple Negative Breast Neoplasms 4Solid Tumor 4

Interventions

pazopanib 3Erlotinib Hydrochloride 3Cetuximab 3Vorinostat 2Oxaliplatin 2Bevacizumab 2Azacitidine 2satraplatin 1ixazomib 1X-Rays 1Valproic Acid 1Trastuzumab 1Sorafenib 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lenalidomide 1Lapatinib 1LY 2275796 1Injections, Subcutaneous 1Fluorouracil 1Everolimus 1Curcumin 1Crizotinib 1Capecitabine 1Albumin-Bound Paclitaxel 1AH 111585 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Cancers × Leucovorin × Clear all
NCT00941499 2015-11-18

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

M.D. Anderson Cancer Center

Phase 1 Completed
140 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡